586
Views
19
CrossRef citations to date
0
Altmetric
Clinical Study

Icodextrine and Insulin Resistance in Continuous Ambulatory Peritoneal Dialysis Patients

&
Pages 289-293 | Published online: 07 Jul 2009

REFERENCES

  • Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998; 53: 1343–1347
  • Stout RW. Diabetes and atherosclerosis—the role of insulin. Diabetologia. 1979; 16: 141–148
  • Moorhead JF, Chan MK, Varghase Z. The role of abnormalities of lipid metabolism in the progression of renal disease. The Progressive Nature of Renal Disease, BM Brenner, JH Stein. Churchill Livingstone, New York, NY 1986; 133–149
  • Ikeda T, Gomi T, Hirawa N, Sakurai J, Yoshikawa N. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension. 1996; 27: 1180–1186
  • Mak RHK, De Fronzo RA. Glucose and insulin metabolism in uremia. Nephron. 1992; 61: 377–382
  • DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest. 1981; 67: 563–570
  • Mak RHK. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol. 1996; 270: F839–844
  • Mak RHK. Metabolic effects of erythropoietin in patients on peritoneal dialysis. Pediatr Nephrol. 1998; 12: 660–665
  • Mak RHK, Turner C, Thompson T, Haycock GB, Chantler C. The effect of dietary protein restriction and amino acid / keto acid suplements on glucose metabolism in uremic patients. J Clin Endocrinol Metab. 1986; 63: 985–989
  • DeFronzo RA, Beckles AD. Glucose intolerance following chronic metabolic acidosis in man. Am J Physiol. 1979; 236: E328–E334
  • Hernandez C, Genesca J, Ignasi Esteban J, Garcia L, Simo R. Relationship between iron stores infected by hepatitis C virus: A case-control study. Med Clin (Barc). Jun 3, 2000; 115(1)21–22
  • Yıldız A, Tutuncu Y, Yazıcı H, Akkaya V, Kayacan SM, Sever MS, et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellutus in renal transplant recipient. Transplantation. Oct 27, 2000; 74(8)1109–1113
  • DeFronzo RA, Tobin JD, Rowe JW, Anders R. Glucose intolerance in uremia: quantification of pancreatic beta cell to glucose and tissue sensitivity to insulin. J Clin Invest. 1978; 62: 425–435
  • Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyper osmolar glucose solutions in CAPD. Midas study group. Multicenter investigation of icodextrin in ambulatory peritoneal dialysis. Kidney Int. 1994; 46: 496–503
  • Brown CB, Gokal R, Mistry CD. Scientific Symposium on Icodextrın in ID, December 1993 London UK. Perit Dial Int. 1994; 14(Suppl 2)
  • Feldman HA, Singer I. Endocrinology and metabolism in uremia and dialysis: a clinical rewiev. Medicine. 1974; 54: 345–376
  • Linder A, Charra B, Sherpard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974; 290: 697–701
  • Kobayashi S, Maejima S, Ikeda T, Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2000; 15: 65–70
  • Delarue J, Maingourd C, Couet C, Vidal S, Bagros P, Lamisse F. Effects of oral glucose on intermediary metabolism in continous ambulatory peritoneal dialysis patients versus healthy subjects. Peritoneal Dial Int. 1998; 18: 505–511
  • Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinsm reduction associated with icodextrin treatment in continous ambulatory peritoneal dialysis patients. Adv Perit Dial. 2001; 17: 80–83
  • Sisca S, Maggiore U. Benefical effect of icodextrin on the hypertriglyceridemia of CAPD patients. Perit Dial Int. 2002; 22: 727–729
  • Mak RHK. 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int. 1992; 41: 1048–1054
  • Borissova AM, Djambazova A, Todorov K, Dakovska L, Tankova T, Kirilov G. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on hemodialysis. Nephrol Dial Transplant. 1993; 8: 93–95
  • Kokot F, Wiecek A, Grzeszczak W. Influence of erythropoietin treatment on endocrine abnormalities in hemodialyzed patients. Erythropoietin: From Molecular Structure to Clinical Application, CA Baldamus, KM Koch, P Scigalla, L Wieczorek. Karger, Basel 1990; 257–272
  • Fadda GZ, Tanakitcharu P, Smogorzewski M, Massry SG. Parathyroid hormone raises citosolic calcium in pancreatic islets: study on mechanisms. Kidney Int. 1993; 43: 554–560
  • Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int. 1994; 46: 496–503
  • Lindholm B, Bergstrom J. Nutritional aspects of CAPD. Continous Ambulatory Peritoneal Dialysis, R Gokal. Churchill Livingstone, Edinburgh 1985; 228–264
  • Holmes C, Shockley T. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000; 20(Suppl. 2)37–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.